{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:40:06Z","timestamp":1786992006097,"version":"build-2736575974"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012411","name":"Alborz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jdiacomp.2024.108867","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:46:40Z","timestamp":1727300800000},"page":"108867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association of detectable C-peptide levels with glycemic control and chronic complications in individuals with type 1 diabetes mellitus: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"39","author":[{"given":"Mahin Seifi","family":"Alan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Tayebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira Jafari","family":"Afshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz Seifi","family":"Alan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz Seifi","family":"Alan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramina","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooba","family":"Sohbatzade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parham","family":"Samimisedeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadith","family":"Rastad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2024.108867_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.16","article-title":"Type 1 diabetes mellitus","volume":"3","author":"Katsarou","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"10.1016\/j.jdiacomp.2024.108867_bb0010","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S2213-8587(23)00123-7","article-title":"Residual insulin secretion in individuals with type 1 diabetes in Finland: longitudinal and cross-sectional analyses","volume":"11","author":"Harsunen","year":"2023","journal-title":"The Lancet Diabetes & Endocrinology"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2337\/dc11-1236","article-title":"Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay","volume":"35","author":"Wang","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0020","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.2337\/db10-0676","article-title":"Residual insulin production and pancreatic \u03b2-cell turnover after 50 years of diabetes: Joslin Medalist Study","volume":"59","author":"Keenan","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0025","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000819","article-title":"Better HbA1c during the first years after diagnosis of type 1 diabetes is associated with residual C peptide 10 years later","volume":"8","author":"Gr\u00f6nberg","year":"2020","journal-title":"BMJ Open Diabetes Research and Care"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-019-1392-8","article-title":"Persistent C-peptide secretion in type 1 diabetes and its relationship to the genetic architecture of diabetes","volume":"17","author":"McKeigue","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0035","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/dme.12850","article-title":"Low levels of C-peptide have clinical significance for established type 1 diabetes","volume":"32","author":"Kuhtreiber","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0040","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1172\/JCI134057","article-title":"High residual C-peptide likely contributes to glycemic control in type 1 diabetes","volume":"130","author":"Rickels","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0045","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/dme.12159","article-title":"The clinical utility of C-peptide measurement in the care of patients with diabetes","volume":"30","author":"Jones","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0050","doi-asserted-by":"crossref","first-page":"9723","DOI":"10.3390\/ijms21249723","article-title":"Biological activity of c-peptide in microvascular complications of type 1 diabetes\u2014time for translational studies or back to the basics?","volume":"21","author":"Ryk","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3514","article-title":"C-peptide, glycaemic control, and diabetic complications in type 2 diabetes mellitus: a real-world study","volume":"38","author":"Huang","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0060","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1210\/jc.2008-1209","article-title":"Rate of \u03b2-cell destruction in type 1 diabetes influences the development of diabetic retinopathy: protective effect of residual \u03b2-cell function for more than 10 years","volume":"93","author":"Nakanishi","year":"2008","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2337\/dc08-1241","article-title":"Fasting plasma C-peptide and micro-and macrovascular complications in a large clinic-based cohort of type 1 diabetic patients","volume":"32","author":"Panero","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0070","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab127","article-title":"Measurement of peak C-peptide at diagnosis informs glycemic control but not hypoglycemia in adults with type 1 diabetes","volume":"5","author":"Carr","year":"2021","journal-title":"Journal of the Endocrine Society"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0075","doi-asserted-by":"crossref","DOI":"10.21037\/atm-20-7471","article-title":"Residual \u03b2-cell function after 10 years of autoimmune type 1 diabetes: prevalence, possible determinants, and implications for metabolism","volume":"9","author":"Cheng","year":"2021","journal-title":"Annals of Translational Medicine"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0080","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2337\/dc20-0567","article-title":"Clinical impact of residual C-peptide secretion in type 1 diabetes on glycemia and microvascular complications","volume":"44","author":"Jeyam","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.869204","article-title":"Insulin requirement and complications associated with serum C-peptide decline in patients with type 1 diabetes mellitus during 15 years after diagnosis","volume":"13","author":"Suh","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0090","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/jdi.13693","article-title":"Impact of flash glucose monitoring on glycemic control varies with the age and residual \u03b2-cell function of patients with type 1 diabetes mellitus","volume":"13","author":"Zhang","year":"2022","journal-title":"Journal of Diabetes Investigation"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2022-002991","article-title":"Higher risk of severe hypoglycemia in children and adolescents with a rapid loss of C-peptide during the first 6 years after type 1 diabetes diagnosis","volume":"10","author":"Gr\u00f6nberg","year":"2022","journal-title":"BMJ Open Diabetes Research and Care."},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0100","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.2337\/dc13-0418","article-title":"Residual \u03b2-cell function 3\u20136 years after onset of type 1 diabetes reduces risk of severe hypoglycemia in children and adolescents","volume":"36","author":"S\u00f8rensen","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0105","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00125-015-3559-y","article-title":"CGM-measured glucose values have a strong correlation with C-peptide, HbA 1c and IDAAC, but do poorly in predicting C-peptide levels in the two years following onset of diabetes","volume":"58","author":"Buckingham","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0110","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/dme.13960","article-title":"Persistent C-peptide is associated with reduced hypoglycaemia but not HbA1c in adults with longstanding type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?","volume":"36","author":"Marren","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0115","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/1753-0407.12912","article-title":"Prognosis for residual islet \u03b2-cell secretion function in young patients with newly diagnosed type 1 diabetes","volume":"11","author":"Miao","year":"2019","journal-title":"J Diabetes"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1297\/cpe.30.27","article-title":"Residual endogenous insulin secretion in Japanese children with type 1A diabetes","volume":"30","author":"Sugihara","year":"2021","journal-title":"Clinical Pediatric Endocrinology"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0125","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/s00125-020-05099-3","article-title":"Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetes","volume":"63","author":"Gibb","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0130","article-title":"Postexercise glycemic control in type 1 diabetes is associated with residual b-cell function","volume":"43","author":"McDonald","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0135","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1111\/jdi.13486","article-title":"Impact of glucagon response on early postprandial glucose excursions irrespective of residual \u03b2-cell function in type 1 diabetes: a cross-sectional study using a mixed meal tolerance test","volume":"12","author":"Ito","year":"2021","journal-title":"Journal of Diabetes Investigation"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0140","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14814","article-title":"Capturing the real-world benefit of residual \u03b2-cell function during clinically important time-periods in established type 1 diabetes","volume":"39","author":"Taylor","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13098-023-01014-z","article-title":"Residual \u03b2-cell function in Brazilian type 1 diabetes after 3 years of diagnosis: prevalence and association with low presence of nephropathy","volume":"15","author":"Gabbay","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0150","doi-asserted-by":"crossref","DOI":"10.1177\/2333794X231159790","article-title":"Correlation of c-peptide with complications observed in children and adolescents with type 1 diabetes in Tanzania: a cross-sectional survey","volume":"10","author":"Majaliwa","year":"2023","journal-title":"Global Pediatric Health"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jcjd.2023.11.001","article-title":"Fasted C-peptide distribution and associated clinical factors in adults with longstanding type 1 diabetes: analysis of the Canadian study of longevity in type 1 diabetes","volume":"48","author":"Lanct\u00f4t","year":"2024","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0160","article-title":"Preserved C-peptide is common and associated with higher time in range in Chinese type 1 diabetes","volume":"15","author":"Liu","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0165","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/07435800.2013.840651","article-title":"Glycemic control and insulin requirements in type 1 diabetic patients depending on the clinical characteristics at diabetes onset","volume":"39","author":"Beato-V\u00edbora","year":"2014","journal-title":"Endocr Res"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0170","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jdiacomp.2019.05.019","article-title":"Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration","volume":"33","author":"Williams","year":"2019","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0175","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1530\/EJE-10-0464","article-title":"Erythropoietin and vascular endothelial growth factor as risk markers for severe hypoglycaemia in type 1 diabetes","volume":"163","author":"Kristensen","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0180","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/1932296816664745","article-title":"Long-term prediction of severe hypoglycemia in type 1 diabetes: is it really possible?","volume":"10","author":"Henriksen","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0185","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002288","article-title":"Residual C-peptide secretion and hypoglycemia awareness in people with type 1 diabetes","volume":"9","author":"Wellens","year":"2021","journal-title":"BMJ Open Diabetes Research and Care"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0190","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3346\/jkms.2013.28.9.1340","article-title":"The clinical measures associated with C-peptide decline in patients with type 1 diabetes over 15 years","volume":"28","author":"Lee","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0195","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/s41598-021-83599-x","article-title":"Relationship of continuous glucose monitoring-related metrics with HbA1c and residual \u03b2-cell function in Japanese patients with type 1 diabetes","volume":"11","author":"Babaya","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0200","article-title":"The impact of body mass index, residual beta cell function and estimated glucose disposal rate on the development of double diabetes and microvascular complications in patients with type 1 diabetes mellitus","volume":"15","author":"Bhagadurshah","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017569","article-title":"HLA genes, islet autoantibodies and residual C-peptide at the clinical onset of type 1 diabetes mellitus and the risk of retinopathy 15 years later","volume":"6","author":"Jensen","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0210","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jdiacomp.2013.12.008","article-title":"Prevalence and risk factors for diabetic retinopathy in Asian Indians with young onset type 1 and type 2 diabetes","volume":"28","author":"Rajalakshmi","year":"2014","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.413","article-title":"Urinary c-peptide creatinine ratio (UCPCR) as a predictor of coronary artery disease in type 1 diabetes mellitus","volume":"6","author":"Irilouzadian","year":"2023","journal-title":"Endocrinology, Diabetes & Metabolism"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0220","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4068\/cmj.2017.53.3.216","article-title":"Factors associated with c-peptide levels after diagnosis in children with type 1 diabetes mellitus","volume":"53","author":"Hwang","year":"2017","journal-title":"Chonnam Med J"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0225","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00125-020-05115-6","article-title":"Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis","volume":"63","author":"team Ts","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0230","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2337\/dc19-0803","article-title":"Genetic variants predisposing most strongly to type 1 diabetes diagnosed under age 7 years lie near candidate genes that function in the immune system and in pancreatic \u03b2-cells","volume":"43","author":"Inshaw","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0235","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00125-013-3067-x","article-title":"The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells","volume":"57","author":"Oram","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0240","first-page":"1","article-title":"History, Normal Physiology, and Production of Insulin","author":"Strachan","year":"2013"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0245","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00125-020-05192-7","article-title":"The making of insulin in health and disease","volume":"63","author":"Vasiljevi\u0107","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0250","series-title":"Towards Optimal Management of Diabetes in Surgery","first-page":"275","article-title":"Insulin pharmacodynamics, pharmacokinetics, and insulin regimens","author":"Kelkar","year":"2019"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0255","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.febslet.2015.01.006","article-title":"C-peptide evolution: generation from few structural restrictions of bioactivities not necessarily functional","volume":"589","author":"Landreh","year":"2015","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0260","doi-asserted-by":"crossref","first-page":"63","DOI":"10.18231\/j.ijnmhs.2023.009","article-title":"Insights on C-peptide in diabetes","volume":"6","author":"Maheshwari","year":"2023","journal-title":"IJNMHS"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0265","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s13300-017-0265-4","article-title":"A practical review of C-peptide testing in diabetes","volume":"8","author":"Leighton","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0270","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/dme.12097","article-title":"Insulin-dose-adjusted HbA <sub>1c<\/sub> -defined partial remission phase in a paediatric population\u2014when is the honeymoon over?","volume":"30","author":"Neylon","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0275","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11340-020-00644-y","article-title":"Effect of glycation on Interlamellar bonding of arterial elastin","volume":"61","author":"Wang","year":"2021","journal-title":"Exp Mech"},{"key":"10.1016\/j.jdiacomp.2024.108867_bb0280","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/ijms21020645","article-title":"Multiple cell Signalling pathways of human proinsulin C-peptide in vasculopathy protection","volume":"21","author":"Souto","year":"2020","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724001934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724001934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:47:25Z","timestamp":1761353245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872724001934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1056872724001934"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108867","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of detectable C-peptide levels with glycemic control and chronic complications in individuals with type 1 diabetes mellitus: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024","name":"copyright","label":"Copyright"}],"article-number":"108867"}}